Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Context matters: the hen or egg problem in Ewing's sarcoma.

Heinrich Kovar1

  • 1Children's Cancer Research Institute, St. Anna Kinderspital, Kinderspitalgasse 6, A-1090 Vienna, Austria. heinrich.kovar@ccri.univie.ac.at

Seminars in Cancer Biology
|April 14, 2005
PubMed
Summary

Ewing

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Mevalonate pathway activation in Ewing sarcoma reveals a 3D-specific synergy between statins and BCL-xL inhibition.

Molecular therapy. Oncology·2026
Same author

Differential immune infiltrates in histomorphologic Wilms tumor regions identify prognostic macrophages.

Molecular therapy. Oncology·2026
Same author

Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma.

EMBO molecular medicine·2026
Same author

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Molecular cancer therapeutics·2025
Same author

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Molecular cancer therapeutics·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing's sarcoma and related tumors (ESFT) are defined by EWS gene fusions with ets family genes.
  • Diagnosis is aided by detecting these gene fusions, but the tumor's tissue of origin remains unclear.
  • Previous studies suggested neuroectodermal origins, but did not account for EWS-ets protein influence on tumor phenotype.

Purpose of the Study:

  • To investigate the cellular origin of ESFT by examining the role of EWS-ets fusion proteins.
  • To address the 'hen or egg' problem: whether ESFT arise from blocked differentiation of a tumor stem cell or imposed differentiation on a precursor.

Main Methods:

  • Review of existing literature on EWS-ets protein activity in various cellular models.
  • Analysis of tissue distribution patterns for FLI1 and ERG gene expression.
  • Examination of evidence for combinatorial control mechanisms influencing EWS-ets activity.

Main Results:

  • EWS-ets proteins induce diverse cellular outcomes, including cell cycle arrest, apoptosis, transformation, and altered differentiation.
  • The molecular phenotype driven by EWS-ets proteins is cell-type dependent.
  • FLI1 and ERG expression patterns and combinatorial control mechanisms are crucial for understanding ESFT development.

Conclusions:

  • The cellular context significantly modulates the oncogenic activity of EWS-ets fusion proteins in ESFT.
  • Understanding the interplay between EWS-ets activity and cellular environment is key to resolving the ESFT tissue of origin debate.
  • Further research into combinatorial gene regulation is needed to fully elucidate ESFT pathogenesis.

Related Experiment Videos